Robert Koska has joined Cepheid as senior vice president of sales and marketing, the company said yesterday. He will replace Ira Marks, who previously held this position. In the past, Koska worked for Vysis U.S., Abbott Molecular Diagnostics, Difco Laboratories, Bristol Myers Genetic Systems, and J&J’s Ortho Diagnostic Systems. He holds an MBA from the University of Michigan, and a BS in medical technology from Wayne State University.
John Burcham has joined Applied Biosystems, as senior marketing manager for TaqMan SNP genotyping assays, GenomeWeb News has learned. He came to ABI from GE Healthcare, formerly Amersham, where he was strategic marketing manager for proteomics. Prior to that, he held technical specialist and marketing positions at Bio-Rad. Burcham holds a BA from the University of California, Berkeley.
Terrie Pizzie will become senior vice president of commercial operations at Biacore International starting March 1, the company said. Prior to joining the company, he was vice president Europe of Applied Biosystems. Before that, he was ABI’s director of sales and marketing in Europe.
William Haseltine, the founder and former CEO of Human Genome Sciences, was named chairman of the scientific advisory board of Matrix Laboratories of Hyderabad, India, earlier this month.
Karen Hahnenberger will leave her position as senior product marketing manager of Eksigent Technologies to join Genentech as publication planning manager. She holds a PhD in molecular biology from Albert Einstein College of Medicine in New York.
Eric Lander will receive this year’s Public Understanding of Science and Technology award from the American Association for the Advancement of Science, AAAS said last week. He is the founding director of the Broad Institute of MIT and Harvard and a professor of biology at MIT, a professor of systems biology at Harvard Medical School, and a member of the Whitehead Institute for Biomedical Research. Lander holds a PhD in mathematics from Oxford University and an undergraduate degree in mathematics from Princeton University.
Mathias Uhlén will receive this year’s Akzo Nobel Science Award on March 15, the Netherlands-based company said yesterday. He is a professor at the Royal Institute of Technology in Stockholm, Sweden. Uhlén receives the 500,000 Swedish kronor ($72,600) award “for his unique research in the field of biotechnology and his ability to bridge research and industry,” according to Akzo. He founded a number of biotechnology companies, including Pyrosequencing, Affibody, Creative Peptides, SweTree Genomics, and Visual Bioinformatics. Uhlén also began a project to map 22,000 human proteins.